'

Advanced Enzymes Technologies conducted conference call on 12 February 2025 to discuss the financial results and performance of the company for the quarter ended December 2024. Mr. Mukund Kabra – Whole-time Director and Mr. Beni Prasad Rauka - Chief Financial Officer along with other senior management of the company addressed the call

Highlights of the Concall

• Revenue increased 5.08% to Rs 169.11 crore in Q3FY25 compared to Q3FY24. The company recognized additional sales of Rs 8 crore which the company was not able to recognize in Q2 since revenue recognition criteria was not made as per the accounting standard.

• Human nutrition segment contributed to 60% of total sales in Q3FY25 and decreased by 8% to Rs 101.8 crore in Q3FY25 as compared to Rs 110.7 crore in Q3FY24.

• Animal nutrition contributed to 12% of total sales in Q3FY25 and delivered a growth of 22% to Rs 19.7 crore compared to Q3FY24

• Bio-processing segment contri...
  
  
  
  Pleaselogin & subscribe to view the full report.
  
  More Reports
  • 

    (05-Feb-2025)

    Castrol India

    Expects EBITDA margin of 22%-25% for CY25
  • 

    (10-Feb-2023)

    Deepak Nitrite

    Plans capex of about Rs 1500 crore for FY23 and FY24
  • 

    (09-Feb-2023)

    Mayur Uniquoters

    Targets revenue of Rs 1000 crore in FY24
  • 

    (31-Jan-2023)

    Tega industries

    Capex plan is US$ 30-32 million for next three years